Dr. Sheila Chari is the Editor-in-Chief at the journal Cell Stem Cell, and Executive Editor at Cell Press. After completing her postdoc, she moved away from the bench and became the Reviews Editor at Cell Stem Cell. As the Editor-in-Chief, Dr. Chari’s primary responsibilities are knowing and publishing the top stem cell discoveries, driving journal publishing strategy, and managing a global editorial staff.

Improved Stem Cell-Derived Beta Cells – The quality of stem cell-derived beta cells can be improved by enriching the culture for specific subpopulations that differentiate homogeneously into pancreatic progenitors.

CRISPR Screening for Tumor Drivers – A new organoid-based platform has been developed to identify drivers of cancer using CRISPR-Cas9.

Working Together to Heal the Heart – Researchers have identified two transcription factors that work together to regulate cardiomyocyte maturation and proliferation, and whose deletion can initiate heart regeneration.

How the Prostate Gland Regenerates – Investigators have found that prostate regeneration is not only driven by rare stem cells, as previously thought, but also by a large population of differentiated cells.

Photo Reference: Courtesy of Dr. Sheila Chari

Never miss updates about new episodes.